Drug Discovery Award supports academic scientists with research resources and biopharma expertise to advance promising cancer targets toward new therapeutic agents and preclinical development.
Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.
Drug Discovery Postdoctoral Fellowship supports postdoctoral researchers’ early-stage drug discovery training to advance therapeutically relevant science with clear potential for translation to humans.
The Lung Cancer Discovery Award from the American Lung Association funds innovative research to advance the science of lung cancer understanding, diagnosis, prevention, and treatment.
Discovery Science Award supports pediatric cancer researchers pursuing bold, early-stage work to develop less toxic, more targeted treatments with potential to advance toward clinical trials.
Drug Discovery Predoctoral Fellowship supports advanced doctoral students pursuing novel, early-stage drug discovery research to develop safe, effective treatments with potential for human translation.